Database Query Results : , , EF-1α
EF-1α, elongation factor 1 alpha: Click to Expand ⟱
| Source: |
| Type: |
Furthermore, overexpression of EF-1α is correlated with increased cell proliferation and oncogenic transformation in breast cancers (20) and is positively associated with prostate cancer progression (21).
a protein that plays a crucial role in the process of protein synthesis (translation) in eukaryotic cells. It is involved in the delivery of aminoacyl-tRNA to the ribosome, facilitating the elongation phase of translation.
EF-1α is often overexpressed in various types of cancer. This overexpression can contribute to the increased protein synthesis required for rapid cell proliferation and tumor growth.
|
Scientific Papers found: Click to Expand⟱
TumCCA↑, CDK2↓, EMT↓, MMPs↓, AMPK↑, TumCI↓, TumCMig↓, TumMeta↓, VEGFR2↓, *antiOx↑, *Inflam↓, *BBB↑, *neuroP↑, *ROS↓, Dose↝, selectivity↑, Casp3↑, Casp9↑, NOTCH1↓, cycD1/CCND1↓, cMyc↓, P21?, DR5↑, cl‑PARP↑, P53↑, Mcl-1↑, p65↓, NF-kB↓, ROS↑, JNK↑, NRF2↑, cJun↑, EF-1α↓, MAPK↓, PI3K↓, mTORC1↓, CSCs↓, OCT4↓, Nanog↓, SOX4↓, STAT3↓, CDK4↓, p‑RB1↓, PGE2↓, COX2↓, β-catenin/ZEB1↑, IKKα↓, HDAC↓, HATs↑, H3↑, H4↑, LC3II↑, c-Raf↓, SIRT3↑, Hif1a↓, ER Stress↑, GRP78/BiP↑, cl‑CHOP↑, MMP↓, PCNA↓, Zeb1↓, NOTCH3↓, CD133↓, Nestin↓, ATG5↑, ATG7↑, survivin↓, ChemoSen↑, SOX2↓, OS↑, P-gp↓, Half-Life↓, Half-Life↝, eff↑, BioAv↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
NRF2↑, 1, ROS↑, 1, SIRT3↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1, c-Raf↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, ATG7↑, 1, cMyc↓, 1,
Cell Death ⓘ
Casp3↑, 1, Casp9↑, 1, DR5↑, 1, JNK↑, 1, MAPK↓, 1, Mcl-1↑, 1, survivin↓, 1,
Kinase & Signal Transduction ⓘ
EF-1α↓, 1,
Transcription & Epigenetics ⓘ
cJun↑, 1, H3↑, 1, H4↑, 1, HATs↑, 1,
Protein Folding & ER Stress ⓘ
cl‑CHOP↑, 1, ER Stress↑, 1, GRP78/BiP↑, 1,
Autophagy & Lysosomes ⓘ
ATG5↑, 1, LC3II↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1, cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 1, P21?, 1, p‑RB1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
CD133↓, 1, CSCs↓, 1, EMT↓, 1, HDAC↓, 1, mTORC1↓, 1, Nanog↓, 1, Nestin↓, 1, NOTCH1↓, 1, NOTCH3↓, 1, OCT4↓, 1, PI3K↓, 1, SOX2↓, 1, STAT3↓, 1,
Migration ⓘ
MMPs↓, 1, SOX4↓, 1, TumCI↓, 1, TumCMig↓, 1, TumMeta↓, 1, Zeb1↓, 1, β-catenin/ZEB1↑, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, VEGFR2↓, 1,
Barriers & Transport ⓘ
P-gp↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IKKα↓, 1, NF-kB↓, 1, p65↓, 1, PGE2↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, ChemoSen↑, 1, Dose↝, 1, eff↑, 1, Half-Life↓, 1, Half-Life↝, 1, selectivity↑, 1,
Functional Outcomes ⓘ
OS↑, 1,
Total Targets: 70
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, ROS↓, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Functional Outcomes ⓘ
neuroP↑, 1,
Total Targets: 5
Scientific Paper Hit Count for: EF-1α, elongation factor 1 alpha
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:91 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page